IntegraGen recently posted their recent colorectal research on Oncotarget. The study linked miR-31-3p expressions to the emergence of metastatic colorectal cancer. Metastatic colorectal cancer, mCRC is a huge menace in the world. Today, there are over 1.3 million new cases of mCRC reported in the US alone. What’s more, the severely debilitating condition reportedly claims the lives of over 650,000 individuals worldwide every year.
IntegraGen is a Paris based research firm trading under the initials, ALINT. The pharmaceutical giant specializes in developing robust and efficient oncology treatment and diagnostic tools. The center shocked the entire oncology world with a medical journal titled, ‘Association between miR-31-3p expression & Cetuximab efficacy in metastatic colorectal cancer patients’. The research demonstrated a strong correlation between the manifestation of cancerous tumors and the expression of the miR-31-3-3p. Additionally, the clinical trials proved the incredible efficiency of the firm’s anti-EGFR cancer treatment.
The historic cancer clinical trial was carried out by a team from the prestigious University College London Cancer Institute led by the oncology expert, Professor John Bridgewater. The professor’s final submissions included similar research findings by the New EPOC cancer research study. Speaking after the publication went live, Prof. Bridgewater termed the anti-EGFR therapy as an absolute game-changer towards treating the virulent colorectal cancer tumors in millions of patients. The professor also commended the partners who’d made the study possible.One of the lead research partners in the oncology findings, Dr. Yann Gaston-Mathe hoped to see more cancer patients recovering thanks to the precision expression testing approach, moving forward. Dr. Yann Gaston-Mathe is a Molecular Diagnostics Director at IntegraGen.
Future Projects by IntegraGen
IntegraGen has in the past worked on CE-IVD markers that are now commercially used all over Europe. The easy to use miRpredX 31-3p marker kits developed by IntegraGen have helped speed up the diagnosis of this cancer variety and consequently, save the lives of millions of cancer patients. IntegraGen is in the process of releasing yet another vital laboratory kit that will be used to measure the expressions of miR-31-3p. The latter project involves the CEBRA laboratories and is scheduled to launch in the coming year.The miRpredX 31-3p test is the world’s premier positive colorectal cancer test. The test helps physicians to determine the best course of treatment for patients who turn up positive. In cases when the cancer is not as advanced, the oncologists resort to using the anti-EGFR therapy as the first-line of defense and in critical cases, the experts go with the chemotherapy option. At times, the physicians see it fit to combine the two therapeutic approaches to save the life of the RAS wild-type colorectal cancer patients.
Oncotarget is on the top 100 list of the most respected American medical journals, according to www.scimagojr.com. The peer-reviewed platform operates on the open access license forum. The platform has encouraged international collaboration among cancer researchers from different corners of the globe. Due to unprecedented demand, the journal publishes weekly periodicals that focus on not just cancer treatments, but a variety of other medical genres as well. Oncotarget is a popular peer-to-peer reviewed medical publication journal founded in late 2010 by the revered cancer researchers, Andrei V. Gudkov and Mikhail Blagosklonny.
Oncotarget is a weekly medical journal that publishes research papers on cancer research and various aspects of oncology. It also publishes papers on endocrinology, immunology, physiology, age-related diseases, and pathology as these all affect tumor development in one way or another. Anyone can access the journal for free. It is peer-reviewed, ensuring that all the information published is accurate.Ever since 2010 when Oncotarget published its first paper, it has done a great job at enlightening the public and those with any kind of interest in developments in the field of oncology and cancer. Andrei Gudkov and Mikhail Blagosklonny are the editors in chief of the journal. When authors submit their manuscripts for consideration, the editors review them and either accept them, recommend a few changes to be made, or reject them. This is all in an effort to ensure the information published in the journal is of high quality and is accurate. The journal has a Creative Commons license, proving its legitimacy.
Effect of Nutrition on Cellular Rejuvenation
One article published by Oncotarget discusses the effect of nutrition on cellular rejuvenation. Nutrition is known to be one of the major factors that affect the rate at which people age and their life expectancy. This is because good nutritional habits decrease the rate of cellular degeneration, and significantly slow down the rate at which people age. A number of tests were done on mice and the findings were consistent with the above. The findings also show why many people in Western societies are suffering from diet-induced health problems. The conclusion drawn from the studies was that restricting daily food intake can greatly decrease the rate of cellular degeneration and significantly extend one’s lifespan.
Oncotarget has been lauded for making it possible for the public to access accurate information on developments of oncology. The journal is a trusted source of information, and is even used by medical students and professionals in their research. With professionals like Oncotarget on the editorial team, it has managed to ensure that its publications are always of the highest quality.
Lifeline Screening is a leading provider that offers a series of preventive health tests. It is community based and involves hands on screenings. The screenings are meant to detect health problems early on. The tests will detect the signs for things like strokes, abdominal aortic aneurysms, carotid artery diseases, and much more. Often times there aren’t any symptoms. It is important to detect health issues ahead of time before they get can get worse and even become terminal. Usually, they can be prevented if they are caught in the early stages.The screenings performed at Lifeline Screening are 100% safe and non-invasive. They are usually fast and painless as well. They have fully trained professionals and the same quality equipment found in hospitals. Results are kept confidential and only shared with the physician. Therefore, the physician and patient can discuss treatment options and handle the problem firsthand.
Some of the tests performed at Lifeline Screening are:
Ultrasound Screenings (Sonography). A test that uses sound waves and images inside the body. It is most reliable for abdominal aortic aneurysm screenings, ankle-brachial index screenings, carotid artery disease screenings, and bone mineral density screenings.
Finger-stick blood screenings. It is one of the more popular screenings provided. It is used to detect problems like diabetes and heart disease. It involves sticking the soft side of the finger and collecting a few drops of blood for testing.
Lifeline Screening provides numerous blood tests such as glucose testing, elevated liver enzymes (ALT/AST) screenings, complete lipid panel testing, and high-sensitivity C-reactive protein (hs-CRP) screenings.All screenings are made to be affordable to patients. They are more focused on providing the best information possible in order to make the process much smoother and easier.Since their beginning in 1993, Lifeline Screening has tested almost eight million people. They are currently screening close to one million individuals every year at more than 16,000 screening events all over the nation. Read full article: Here.